Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - VERDE BIO HOLDINGS, INC.Financial_Report.xls
EX-31.02 - EXHIBIT 31.02 SECTION 302 CERTIFICATION - VERDE BIO HOLDINGS, INC.f10q073114_ex31z02.htm
EX-32.01 - EXHIBIT 32.01 SECTION 906 CERTIFICATION - VERDE BIO HOLDINGS, INC.f10q073114_ex32z01.htm
EX-31.01 - EXHIBIT 31.01 SECTION 302 CERTIFICATION - VERDE BIO HOLDINGS, INC.f10q073114_ex31z01.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 


FORM 10-Q


  X .

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 31, 2014


      .

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from ______ to _______


Commission File Number 000-54524


APPIPHANY TECHNOLOGIES HOLDINGS CORP.

[f10q073114_10q001.jpg]

(Name of small business issuer in its charter)


Nevada

 

30-0678378

(State of incorporation)

 

(I.R.S. Employer Identification No.)


P.O. Box 21101 Orchard Park

Kelowna, B.C.

Canada V1Y 9N8

(Address of principal executive offices)

 

(205) 864-5377

(Registrant’s telephone number)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes  X . No      .


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes      . No  X . (Not required)


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.


Large accelerated filer

      .

Accelerated filer

      .

Non-accelerated filer

      . (Do not check if a smaller reporting company)

Smaller reporting company

  X .


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes      . No  X .


As of September 23, 2014, there were 58,050,672 shares of the registrant’s $0.001 par value common stock issued and outstanding.




1




APPIPHANY TECHNOLOGIES HOLDINGS CORP.*



TABLE OF CONTENTS

 

Page

 

 

 

 

PART I.

FINANCIAL INFORMATION

 

 

 

 

 

 

ITEM 1.

FINANCIAL STATEMENTS

 

3

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

14

ITEM 3.

QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK

 

16

ITEM 4.

CONTROLS AND PROCEDURES

 

16

 

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

 

 

ITEM 1.

LEGAL PROCEEDINGS

 

17

ITEM 1A.

RISK FACTORS

 

17

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

17

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

 

18

ITEM 4.

MINE SAFETY DISCLOSURES

 

18

ITEM 5.

OTHER INFORMATION

 

18

ITEM 6.

EXHIBITS

 

18




2




Special Note Regarding Forward-Looking Statements


Information included in this Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”).  This information may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Appiphany Technologies Holdings Corp. (the “Company”), to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements.  Forward-looking statements, which involve assumptions and describe future plans, strategies and expectations of the Company, are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology.  These forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that these projections included in these forward-looking statements will come to pass.  Actual results of the Company could differ materially from those expressed or implied by the forward-looking statements as a result of various factors.  Except as required by applicable laws, the Company has no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.


*Please note that throughout this Quarterly Report, except as otherwise indicated by the context, references in this report to “Company”, “APHD”, “we”, “us” and “our” are references to Appiphany Technologies Holdings Corp.



3

















APPIPHANY TECHNOLOGIES HOLDINGS CORP.


Condensed Consolidated Financial Statements


For the Three Months Ended July 31, 2014






















Condensed Consolidated Balance Sheets

5

Condensed Consolidated Statements of Operations

6

Condensed Consolidated Statements of Cash Flows

7

Notes to the Condensed Consolidated Financial Statements

8




4



APPIPHANY TECHNOLOGIES HOLDINGS CORP.

Condensed Consolidated Balance Sheets

(Expressed in US dollars)


 

 

 July 31,

 2014

 $

 

April 30,

2014

$

 

 

(Unaudited)

 

 

ASSETS

 

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

 

 

 

Cash

 

34,194

 

5,202

Accounts receivable

 

252

 

91

Prepaid expense

 

3,483

 

 

 

 

 

 

Total Assets

 

37,929

 

5,293

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

66,774

 

77,471

Accrued compensation

 

57,900

 

42,900

Due to related parties

 

33,196

 

47,696

Convertible debenture, net of unamortized discount of $32,099 and $4,560, respectively

 

96,901

 

58,840

Derivative liability

 

88,077

 

47,706

 

 

 

 

 

Total Liabilities

 

342,848

 

274,613

 

 

 

 

 

STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

 

Preferred stock

 

 

 

 

Authorized: 10,000,000 preferred shares with a par value of $0.001 per share

 

 

 

 

Issued and outstanding: nil preferred shares

 

 

 

 

 

 

 

Common stock

 

 

 

 

Authorized: 250,000,000 common shares with a par value of $0.001 per share

 

 

 

 

Issued and outstanding: 35,219,481 and 22,177,277 common shares, respectively

 

35,220

 

22,177

 

 

 

 

 

Additional paid-in capital

 

620,843

 

576,491

 

 

 

 

 

Accumulated deficit

 

(960,982)

 

(867,988)

 

 

 

 

 

Total Stockholders’ Deficit

 

(304,919)

 

(269,320)

 

 

 

 

 

Total Liabilities and Stockholders’ Deficit

 

37,929

 

5,293


(The accompanying notes are an integral part of these condensed consolidated financial statements)




5



APPIPHANY TECHNOLOGIES HOLDINGS CORP.

Condensed Consolidated Statements of Operations

(Expressed in US dollars)

(Unaudited)


 

 

For the three months ended

July 31,

2014

$

 

For the three months ended

July 31,

2013

$

Revenues

 

228

 

170

 

 

 

 

 

 

 

228

 

170

 

 

 

 

 

Operating Expenses

 

 

 

 

 

 

 

 

 

Consulting fees

 

1,750

 

22,686

Depreciation

 

 

97

General and administrative

 

4,973

 

(543)

Management fees

 

15,000

 

24,000

Professional fees

 

11,236

 

11,490

 

 

 

 

 

Total Operating Expenses

 

32,959

 

57,730

 

 

 

 

 

Net loss before other expenses

 

(32,731)

 

(57,560)

 

 

 

 

 

Other Income (Expenses)

 

 

 

 

Accretion of discount on convertible notes payable

 

(4,961)

 

Financing cost

 

(1,017)

 

(2,500)

Interest expense

 

(3,023)

 

(506)

Loss on change in fair value of derivative liability

 

(51,262)

 

 

 

 

 

 

Total Other Income (Expenses)

 

(60,263)

 

(3,006)

 

 

 

 

 

Net Loss

 

(92,994)

 

(60,566)


Net Loss Per Share – Basic and Diluted        

 

(0.00)

 

(0.01)


Weighted Average Shares Outstanding – Basic and Diluted

 

28,179,031

 

9,837,038

 

 

 

 

 


(The accompanying notes are an integral part of these condensed consolidated financial statements)




6



APPIPHANY TECHNOLOGIES HOLDINGS CORP.

Condensed Consolidated Statements of Cashflow

(Expressed in US dollars)

(Unaudited)


 

 

For the three months ended

July 31,

2014

$

 

For the three months ended

July 31,

2013

$

Operating Activities

 

 

 

 

 

 

 

 

 

Net loss

 

(92,994)

 

(60,566)

 

 

 

 

 

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

Accretion of discount on convertible debt payable

 

4,961

 

Depreciation

 

 

97

Expenses paid by related party

 

 

105

Financing costs

 

1,017

 

Loss on change in fair value of derivative liability

 

51,262

 

 

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

Accounts receivable

 

(161)

 

Prepaid expense

 

 

22,686

Accounts payable and accrued liabilities

 

(8,593)

 

(17,079)

Accrued compensation

 

15,000

 

24,000

 

 

 

 

 

Net Cash Used In Operating Activities

 

(29,508)

 

(30,757)

 

 

 

 

 

Financing Activities

 

 

 

 

 

 

 

 

 

Proceeds from convertible debenture

 

73,000

 

32,500

Repayment on related party payable

 

(14,500)

 

 

 

 

 

 

Net Cash Provided by Financing Activities

 

58,500

 

32,500

 

 

 

 

 

Increase in Cash

 

28,992

 

1,743

 

 

 

 

 

Cash – Beginning of Period

 

5,202

 

112

 

 

 

 

 

Cash – End of Period

 

34,194

 

1,855

 

 

 

 

 

Supplemental Disclosures

 

 

 

 

 

 

 

 

 

Interest paid

 

 

Income tax paid

 

 

 

 

 

 

 

Non-cash investing and financing activities

 

 

 

 

 

 

 

 

 

Common stock issued for conversion of convertible debt

 

57,394

 

 

 

 

 

 




7



APPIPHANY TECHNOLOGIES HOLDINGS CORP.

Notes to the Consolidated Financial Statements

(Expressed in US dollars)


1.

Nature of Operations and Continuance of Business


The Company was incorporated in the State of Nevada on February 24, 2010. On May 1, 2010, the Company entered into a share exchange agreement with Appiphany Technologies Corporation (“ATC”) to acquire all of the outstanding common shares of ATC in exchange for 1,500,000 common shares of the Company.  As the acquisition involved companies under common control, the acquisition was accounted for in accordance with ASC 805-50, Business Combinations – Related Issues, and the consolidated financial statements reflect the accounts of the Company and ATC since inception.  


Going Concern


These consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. As at July 31, 2014, the Company has not recognized significant revenue, has a working capital deficit of $304,919, and has an accumulated deficit of $960,982. The continuation of the Company as a going concern is dependent upon the continued financial support from its management, and its ability to identify future investment opportunities and obtain the necessary debt or equity financing, and generating profitable operations from the Company’s future operations. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.  These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.  


2.

Summary of Significant Accounting Policies


a)

Basis of Presentation


The consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in U.S. dollars.  The Company’s fiscal year end is April 30.


b)

Use of Estimates


The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the fair value and estimated useful life of long-lived assets, fair value of convertible debentures, stock-based compensation, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.


c)

Interim Condensed Consolidated Financial Statements


These interim condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period.



8




2.

Summary of Significant Accounting Policies (continued)


d)

Cash and cash equivalents


The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. As at July 31 and April 30, 2014, the Company had no items representing cash equivalents.


e)

Basic and Diluted Net Loss per Share


The Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti dilutive.  As of July 31, 2014, the Company had 72,128,851 (April 30, 2014 – 20,196,079) potentially dilutive shares outstanding.


f)

Financial Instruments


Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:


Level 1


Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.


Level 2


Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.


Level 3


Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.


The Company’s financial instruments consist principally of cash, amounts receivable, accounts payable and accrued liabilities, accrued compensation, and amounts due to related parties.  Pursuant to ASC 820, the fair value of our cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The fair value of our derivative liability is determined to be a “Level 2” input.  We believe that the recorded values of all of our other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.



9




2.

Summary of Significant Accounting Policies (continued)


g)

Comprehensive Loss


ASC 220, Comprehensive Income, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at July 31 and April 30, 2014, the Company has no items that represent a comprehensive loss and, therefore, has not included a schedule of comprehensive loss in the financial statements.


h)

Revenue Recognition


The Company recognizes revenue from online advertising. Revenue will be recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service has been provided, and collectability is assured.  The Company is not exposed to any credit risks as amounts are prepaid prior to performance of services.  


i)

Reclassification


Certain balances in previously issued financial statements have been reclassified to be consistent with the current period presentation.  


j)

Stock-based Compensation


The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation and ASC 505, Equity Based Payments to Non-Employees, which requires the measurement and recognition of compensation expense based on estimated fair values for all share-based awards made to employees and directors, including stock options.


ASC 718 requires company to estimate the fair value of share-based awards on the date of grant using an option-pricing model.  The Company uses the Black-Scholes option pricing model as its method of determining fair value.  This model is affected by the Company’s stock price as well as assumptions regarding a number of subjective variables.  These subjective variables include, but are not limited to the Company’s expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviours.  The value of the portion of the award that is ultimately expected to vest is recognized as an expense in the statement of operations over the requisite service period.


All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.


k)

Recent Accounting Pronouncements


The Company has limited operations and is considered to be in the exploration stage. In the period ended July 31, 2014, the Company has elected to early adopt Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. The adoption of this ASU allows the Company to remove the inception to date information and all references to exploration stage.

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.



10




3.

Related Party Transactions


a)

During the three months ended July 31, 2014, the Company incurred $15,000 (2013 - $15,000) of management fees to the President and Director of the Company. As at July 31, 2014, the Company owed $48,900 (April 30, 2014 - $33,900) in accrued compensation.


b)

During the three months ended July 31, 2014, the Company incurred $nil (2013 – $9,000) of management fees to the former Secretary and Treasurer of the Company. As at July 31, 2014, the Company owed $9,000 (April 30, 2014 - $9,000) in accrued compensation.


c)

As at July 31, 2014, the Company owed $33,196 (April 30, 2014 - $47,696) to the President and Director of the Company for financing of day-to-day expenditures incurred on behalf of the Company.  The amounts owing are unsecured, non-interest bearing, and due on demand.


d)

As at July 31, 2014, the Company owed $548 (April 30, 2014 - $548) of professional fees paid on its behalf by the former Secretary and Treasurer of the Company, which is included in accounts payable and accrued liabilities.


4.

Common Shares


a)

On May 19, 2014, the Company issued 2,012,500 common shares upon the conversion of $2,415 of convertible notes payable as described in Note 5.


b)

On May 21, 2014, the Company issued 2,192,308 common shares upon the conversion of $2,850 of convertible notes payable as described in Note 5.


c)

On June 4, 2014, the Company issued 2,208,333 common shares upon the conversion of $2,650 of convertible notes payable as described in Note 5.


d)

On June 23, 2014, the Company issued 2,215,000 common shares upon the conversion of $2,215 of convertible notes payable as described in Note 5.


e)

On July 22, 2014, the Company issued 2,210,938 common shares upon the conversion of $1,415 of convertible notes payable as described in Note 5.


f)

On July 28, 2014, the Company issued 2,203,125 common shares upon the conversion of $355 of convertible notes payable and $1,055 accrued interest payable as described in Note 5.


5.

Convertible Debentures


a)

On May 21, 2013, the Company issued a convertible debenture, to a non-related party, for proceeds of $32,500. Under the terms of the debenture, the amount owing is unsecured, bears interest at 8% per annum, and is due on February 28, 2014. Interest on overdue principal after default accrues at an annual rate of 22%. After 180 days or November 16, 2013, the debenture is convertible into common shares of the Company at a conversion price equal to 51% of the lowest two trading prices of the Company’s common shares for the past 30 trading days prior to notice of conversion.


Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $32,500. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $32,500. During the period ended July 31, 2014, the Company issued 13,042,204 shares of common stock for the conversion of $11,900 of the note and $1,055 of accrued interest. As at July 31, 2014, the carrying value of the note was $nil (April 30, 2014 - $11,900).



11




5.

Convertible Debentures (continued)


b)

On September 3, 2013, the Company issued a convertible debenture, to a non-related party, for proceeds of $19,000. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and is due on June 5, 2014. Interest on overdue principal after default accrues at an annual rate of 22%. After 180 days or March 2, 2014, the debenture is convertible into common shares of the Company at a conversion price equal to 51% of the lowest two trading prices of the Company’s common shares for the past 30 trading days prior to notice of conversion.


Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $19,000. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $19,000. As at July 31, 2014, the carrying value of the note was $19,000 and $4,560 of accretion expense had been recorded.


c)

On December 17, 2013, the Company issued a convertible debenture, to a non-related party, for proceeds of $32,500. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and is due on September 19, 2014. Interest on overdue principal after default accrues at an annual rate of 22%. After 180 days or June 15, 2014, the debenture is convertible into common shares of the Company at a conversion price equal to 51% of the lowest two trading prices of the Company’s common shares for the past 30 trading days prior to notice of conversion.


Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $32,500. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $32,500. As at July 31, 2014, the carrying value of the note was $401 and $401 of accretion expense had been recorded.


d)

On May 21, 2014, the Company issued a convertible debenture, to a non-related party, for proceeds of $37,500. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and is due on February 23, 2015. After 180 days or November 17, 2014, the debenture is convertible into common shares of the Company at a conversion price equal to 51% of the lowest two trading prices of the Company’s common shares for the past 30 trading days prior to notice of conversion.


The Company analyzed the conversion option of the KBM note for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion feature should be classified as a liability. However, due to the conversion option not being effective until November 17, 2014, the Company will delay measuring the derivative liability until such date.


e)

On May 23, 2014, the Company issued a convertible debenture, to a non-related party, for proceeds of $40,000. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and is due on May 23, 2015. After 180 days or November 19, 2014, the debenture is convertible into common shares of the Company at a conversion price equal to 55% of the lowest trading price of the Company’s common shares for the past 15 trading days prior to notice of conversion.


The Company analyzed the conversion option of the LG Capital note for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion feature should be classified as a liability. However, due to the conversion option not being effective until November 19, 2014, the Company will delay measuring the derivative liability until such date.  



12




6.

Subsequent Events


We have evaluated subsequent events through the date of issuance of the financial statements, and did not have any material recognizable subsequent events after July 31, 2014, excepting the following:


a)

On August 12, 2014, the Company issued 1,922,535 common shares upon the conversion of $1,365 of convertible notes payable.


b)

On August 12, 2014, the Company issued 1,591,549 common shares upon the conversion of $1,130 of convertible notes payable.


c)

On August 18, 2014, the Company issued 3,514,085 common shares upon the conversion of $2,495 of convertible notes payable.


d)

On August 22, 2014, the Company issued 3,514,085 common shares upon the conversion of $2,495 of convertible notes payable.


e)

On August 28, 2014, the Company issued 3,507,246 common shares upon the conversion of $2,420 of convertible notes payable.


f)

On September 5, 2014, the Company issued 3,514,085 common shares upon the conversion of $2,495 of convertible notes payable.


g)

On September 12, 2014, the Company issued 5,267,606 common shares upon the conversion of $3,740 of convertible notes payable.


END NOTES TO FINANCIALS



13




ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION OR PLAN OF OPERATION


FORWARD-LOOKING STATEMENTS


This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements are not historical facts but rather are based on current expectations, estimates and projections. We may use words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “foresee,” “estimate” and variations of these words and similar expressions to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted. You should read this report completely and with the understanding that actual future results may be materially different from what we expect. The forward-looking statements included in this report are made as of the date of this report and should be evaluated with consideration of any changes occurring after the date of this Report. We will not update forward-looking statements even though our situation may change in the future and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.


RESULTS OF OPERATIONS


Working Capital


 

 

July 31, 2014

$

 

April 30, 2014

$

Current Assets

 

37,929

 

5,293

Current Liabilities

 

342,848

 

274,613

Working Capital (Deficit)

 

(304,919)

 

(269,320)


Cash Flows


 

 

For the three months ended July 31,

2014

$

 

For the three months ended July 31,

2013

$

Cash Flows used in Operating Activities

 

(29,508 )

 

(30,757)

Cash Flows from (used in) Investing Activities

 

-

 

-

Cash Flows from (used in) Financing Activities

 

58,500

 

32,500

Net increase (decrease) in Cash During Period

 

28,992

 

1,743


Operating Revenues


For the three months ended July 31, 2014, the Company earned revenues of $228 compared with $170 for the three months ended July 31, 2013.  


Operating Expenses and Net Loss


For the three months ended July 31, 2014, the Company incurred operating expenses of $32,959 compared with $57,730 for the three months ended July 31, 2013.  The decrease in operating expenses were related to a decrease in consulting fees and management fees.



14




For the three months ended July 31, 2014, the Company had a net loss of $92,994 compared with a net loss of $60,566 for the three months ended July 31, 2013.  The increase in net loss for the period ended July 31, 2014 as compared to the same period in 2013 can be attributed to an increase in loss on change in fair value of derivative liability.  


Liquidity and Capital Resources


As at July 31, 2014, the Company had $34,194 in cash and total assets of $37,929 as compared to cash of $5,202 and total assets of $5,293 as at April 30, 2013. The increase in cash and total assets were attributed to debt financing of $32,500 received by the Company.


As at July 31, 2014, the Company had total liabilities of $342,848 compared with total liabilities of $274,613 at April 30, 2013. The increase in total liabilities can be attributed to an increase in derivative liability and convertible debentures.


As at July 31, 2014, the Company had a working capital deficit of $304,919 compared with a working capital deficit of $269,320 as at April 30, 2013. The increase in working capital deficit was due to an increase in total liabilities due to new convertible debentures and a decrease in total assets due to a decrease in prepaid expenses.


Cash Flow from Operating Activities


During the three month period ended July 31, 2014, the Company used $29,508 of cash for operating activities compared to the use of $30,757 of cash for operating activities during the three month period ended July 31, 2013.


Cash Flow from Financing Activities


During the three month period ended July 31, 2014, the Company received $58,500 of cash from financing activities compared to the use of $32,500 for the three month period ended July 31, 2013.  During the current period, the Company received $73,000 in proceeds from the issuance of convertible debentures less $14,500 for the repayment of amounts owing to related parties.


Going Concern


We have not attained profitable operations and are dependent upon obtaining financing to pursue any extensive acquisitions and activities.  For these reasons, our auditors stated in their report on our audited financial statements that they have substantial doubt that we will be able to continue as a going concern without further financing. 


Future Financings


We will continue to rely on equity sales of our Common Shares in order to continue to fund our business operations.  Issuances of additional shares will result in dilution to existing stockholders.  There is no assurance that we will achieve any additional sales of the equity securities or arrange for debt or other financing to fund our operations and other activities.


Off-Balance Sheet Arrangements


We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.


Critical Accounting Policies


Our financial statements and accompanying notes have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis.  The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.



15




We regularly evaluate the accounting policies and estimates that we use to prepare our financial statements. A complete summary of these policies is included in the notes to our financial statements.  In general, management's estimates are based on historical experience, on information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances.  Actual results could differ from those estimates made by management.


Recently Issued Accounting Pronouncements


The Company has implemented all new accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.


ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.


ITEM 4.

CONTROLS AND PROCEDURES


Evaluation of Disclosure Controls and Procedures


Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms.  Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by our company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management carried out an evaluation under the supervision and with the participation of our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 ("Exchange Act").  Based upon that evaluation, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were not effective as of April 30, 2014, due to the material weaknesses resulting from the Board of Directors not currently having any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-K, and controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements.  Please refer to our Annual Report on Form 10-K as filed with the SEC on August 11, 2014, for a complete discussion relating to the foregoing evaluation of Disclosures and Procedures.

 

Changes in Internal Control over Financial Reporting

 

Our management has also evaluated our internal control over financial reporting, and there have been no significant changes in our internal controls or in other factors that could significantly affect those controls subsequent to the date of our last evaluation.

 

The Company is not required by current SEC rules to include, and does not include, an auditor's attestation report. The Company's registered public accounting firm has not attested to Management's reports on the Company's internal control over financial reporting.



16




PART II - OTHER INFORMATION


ITEM 1.

LEGAL PROCEEDINGS.


We know of no material, existing or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation.  There are no proceedings in which our director, officer or any affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.


ITEM 1A.

RISK FACTORS.


We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.


ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.


1.

Quarterly Issuances:


On May 19, 2014, the Company issued 2,012,500 common shares upon the conversion of $2,415 of convertible notes payable.


On May 21, 2014, the Company issued 2,192,308 common shares upon the conversion of $2,850 of convertible notes payable.


On June 4, 2014, the Company issued 2,208,333 common shares upon conversion of $2,650 of convertible notes payable.


On June 23, 2014, the Company issued 2,215,000 common shares upon conversion of $2,215 of convertible notes payable.


On July 22, 2014, the Company issued 2,210,937 common shares upon conversion of $1,415 of convertible notes payable.  


On July 28, 2014, the Company issued 2,203,125 common shares upon the conversion of $355 of convertible notes payable and $1,055 accrued interest payable.


2.

Subsequent Issuances:


On August 12, 2014, the Company issued 1,922,535 common shares upon the conversion of $1,365 of convertible notes payable.  


On August 12, 2014, the Company issued 1,591,549 common shares upon the conversion of $1,130of convertible notes payable.  


On August 18, 2014, the Company issued 3,514,085 common shares upon the conversion of $2,495 of convertible notes payable.  


On August 22, 2014, the Company issued 3,514,085 common shares upon the conversion of $2,495 of convertible notes payable.  


On August 28, 2014, the Company issued 3,507,246 common shares upon the conversion of $2,420 of convertible notes payable.  


On September 5, 2014, the Company issued 3,514,085 common shares upon the conversion of $2,495 of convertible notes payable.  


On September 12, 2014, the Company issued 5,267,606 common shares upon the conversion of $3,740 of convertible notes payable.



17




ITEM 3.

DEFAULTS UPON SENIOR SECURITIES.


None.


ITEM 4.

MINE SAFETY DISCLOSURES.


Not Applicable.


ITEM 5.

OTHER INFORMATION.


None.


ITEM 6.

EXHIBITS


Exhibit

Number

 

Description of Exhibit

 

Filing

3.01

 

Articles of Incorporation

 

Filed with the SEC on June 11, 2010 as part of our Registration Statement on Form S-1.

3.02

 

Bylaws

 

Filed with the SEC on June 11, 2010 as part of our Registration Statement on Form S-1.

4.01

 

2012 Equity Incentive Plan

 

Filed with the SEC on November 9, 2012 as part of our Registration Statement on Form S-8.

10.01

 

Share Exchange Agreement between the Company and Appiphany Technologies Corp. dated May 1, 2010

 

Filed with the SEC on June 11, 2010 as part of our Registration Statement on Form S-1.

10.02

 

Contract License Agreement between Appiphany Technologies Corp. and Apple, Inc. dated September 25, 2009

 

Filed with the SEC on June 11, 2010 as part of our Registration Statement on Form S-1.

10.03

 

Promissory Note between the Company and Scott Osborne dated July 22, 2010

 

Filed with the SEC on November 4, 2010 as part of our Amended Registration Statement on Form S-1/A.

10.04

 

Promissory Note between the Company and Fraser Tolmie dated October 28, 2010

 

Filed with the SEC on November 4, 2010 as part of our Amended Registration Statement on Form S-1/A.

10.05

 

Promissory Note between the Company and Darren Wright dated October 28, 2010

 

Filed with the SEC on November 4, 2010 as part of our Amended Registration Statement on Form S-1/A.

10.06

 

Promissory Note between the Company and Joshua Kostyniuk dated October 28, 2010

 

Filed with the SEC on November 4, 2010 as part of our Amended Registration Statement on Form S-1/A.

10.07

 

Consulting Agreement between the Company and Voltaire Gomez dated September 23, 2010

 

Filed with the SEC on November 4, 2010 as part of our Amended Registration Statement on Form S-1/A.

10.08

 

Consulting Agreement between the Company and Garth Roy dated January 16, 2012

 

Filed with the SEC on January 18, 2012 as part of our Current Report on Form 8-K.

10.09

 

Consulting Agreement between the Company and Brian D. Jones dated November 9, 2012

 

Filed with the SEC on November 19, 2012 as part of our Current Report on Form 8-K.

10.10

 

Consulting Agreement between the Company and Jon Trump dated November 27, 2012

 

Filed with the SEC on November 29, 2012 as part of our Current Report on Form 8-K.

10.11

 

Consulting Agreement between the Company and Jon Trump dated March 1, 2013

 

Filed with the SEC on March 5, 2013 as part of our Current Report on Form 8-K.

16.01

 

Letter from M&K CPAS, PLLC dated September 19, 2011

 

Filed with the SEC on September 19, 2011 as part of our Current Report on Form 8-K.

21.01

 

List of Subsidiaries

 

Filed with the SEC on November 4, 2010 as part of our Amended Registration Statement on Form S-1/A.

31.01

 

Certification of Principal Executive Officer Pursuant to Rule 13a-14

 

Filed herewith.

31.02

 

Certification of Principal Financial Officer Pursuant to Rule 13a-14

 

Filed herewith.

32.01

 

CEO and CFO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act

 

Filed herewith.

101.INS*

 

XBRL Instance Document

 

Filed herewith.

101.SCH*

 

XBRL Taxonomy Extension Schema Document

 

Filed herewith.

101.CAL*

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

Filed herewith.

101.LAB*

 

XBRL Taxonomy Extension Labels Linkbase Document

 

Filed herewith.

101.PRE*

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

Filed herewith.

101.DEF*

 

XBRL Taxonomy Extension Definition Linkbase Document

 

Filed herewith.


*Pursuant to Regulation S-T, this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.



18




SIGNATURES


In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 

 

APPIPHANY TECHNOLOGIES HOLDINGS CORP.

 

 

 

Dated: September 29, 2014

 

/s/ Jesse Keller

 

 

By: Jesse Keller

 

 

Its: President, Principal Executive Officer, Principal Accounting Officer, Secretary, Treasurer & Director


In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated.


Dated: September 29, 2014

/s/ Jesse Keller

 

By: Jesse Keller

 

Its: President, Principal Executive Officer, Principal Accounting Officer, Secretary, Treasurer & Director




19